Key result
Case-control study examines coagulation and inflammatory serum markers in dementia without reporting quantitative outcomes.
Case-Control
Alzheimer's disease is classified as a degenerative dementia while vascular dementia is known to be associated with atherothrombosis and classical vascular risk factors. However, over the last decade, there is increasing evidence of the role of haemostatic factors and inflammatory mechanisms in the pathogenesis of Alzheimer's disease. Serum markers of hypercoagulability and markers of inflammation could lead to thrombosis, accelerated atherogenesis and resulting dementia of both Alzheimer's and vascular dementia. In this case control study, we studied these serum markers of coagulation and inflammation in patients suffering from dementia.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2004) conducted a case-control in Alzheimer's and vascular dementia. Serum markers of coagulation and inflammation was evaluated. The abstract describes a case-control study investigating serum markers of coagulation and inflammation in dementia without reporting quantitative results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: